Advertisement

Index by author

May 01, 2013; Volume 345,Issue 2

  1. Abais, Justine M.

    1. Attenuation by Statins of Membrane Raft-Redox Signaling in Coronary Arterial Endothelium
      Yu-Miao Wei, Xiang Li, Jing Xiong, Justine M. Abais, Min Xia, Krishna M. Boini, Yang Zhang and Pin-Lan Li
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 170-179; DOI: https://doi.org/10.1124/jpet.112.201442

  2. Abood, Mary E.

    1. Novel Insights into CB1 Cannabinoid Receptor Signaling: A Key Interaction Identified between the Extracellular-3 Loop and Transmembrane Helix 2
      Jahan Marcu, Derek M. Shore, Ankur Kapur, Megan Trznadel, Alexandros Makriyannis, Patricia H. Reggio and Mary E. Abood
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 189-197; DOI: https://doi.org/10.1124/jpet.112.201046

  3. Agarwal, Chapla

    1. Silibinin Synergizes with Histone Deacetylase and DNA Methyltransferase Inhibitors in Upregulating E-cadherin Expression Together with Inhibition of Migration and Invasion of Human Non-small Cell Lung Cancer Cells
      Samiha Mateen, Komal Raina, Chapla Agarwal, Daniel Chan and Rajesh Agarwal
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 206-214; DOI: https://doi.org/10.1124/jpet.113.203471

  4. Agarwal, Rajesh

    1. Silibinin Synergizes with Histone Deacetylase and DNA Methyltransferase Inhibitors in Upregulating E-cadherin Expression Together with Inhibition of Migration and Invasion of Human Non-small Cell Lung Cancer Cells
      Samiha Mateen, Komal Raina, Chapla Agarwal, Daniel Chan and Rajesh Agarwal
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 206-214; DOI: https://doi.org/10.1124/jpet.113.203471

  5. Ancona, Silvia

    1. Chromatin Remodeling by Rosuvastatin Normalizes TSC2-/meth Cell Phenotype through the Expression of Tuberin
      Elena Lesma, Silvia Ancona, Emanuela Orpianesi, Vera Grande, Anna Maria Di Giulio and Alfredo Gorio
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 180-188; DOI: https://doi.org/10.1124/jpet.113.203141

  6. Barrett, Victoria J.

    1. Pharmacological Characterization of GSK573719 (Umeclidinium): A Novel, Long-Acting, Inhaled Antagonist of the Muscarinic Cholinergic Receptors for Treatment of Pulmonary Diseases
      Michael Salmon, Mark A. Luttmann, James J. Foley, Peter T. Buckley, Dulcie B. Schmidt, Miriam Burman, Edward F. Webb, Christopher J. DeHaas, Charles J. Kotzer, Victoria J. Barrett, Robert J. Slack, Henry M. Sarau, Michael R. Palovich, Dramane I. Lainé, Douglas W. P. Hay and William L. Rumsey
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 260-270; DOI: https://doi.org/10.1124/jpet.112.202051

  7. Blair, Ian A.

    1. A Novel Nontoxic Inhibitor of the Activation of NADPH Oxidase Reduces Reactive Oxygen Species Production in Mouse Lung
      Intae Lee, Chandra Dodia, Shampa Chatterjee, John Zagorski, Clementina Mesaros, Ian A. Blair, Sheldon I. Feinstein, Mahendra Jain and Aron B. Fisher
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 284-296; DOI: https://doi.org/10.1124/jpet.112.201079

  8. Boini, Krishna M.

    1. Attenuation by Statins of Membrane Raft-Redox Signaling in Coronary Arterial Endothelium
      Yu-Miao Wei, Xiang Li, Jing Xiong, Justine M. Abais, Min Xia, Krishna M. Boini, Yang Zhang and Pin-Lan Li
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 170-179; DOI: https://doi.org/10.1124/jpet.112.201442

  9. Bouchara, Jean-Philippe

    1. Experimental Models of Disseminated Scedosporiosis with Cerebral Involvement
      Bénédicte Lelièvre, Pierre Legras, Charlotte Godon, Florence Franconi, Jean-Paul Saint-André, Jean-Philippe Bouchara and Bertrand Diquet
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 198-205; DOI: https://doi.org/10.1124/jpet.112.201541

  10. Buckley, Peter T.

    1. Pharmacological Characterization of GSK573719 (Umeclidinium): A Novel, Long-Acting, Inhaled Antagonist of the Muscarinic Cholinergic Receptors for Treatment of Pulmonary Diseases
      Michael Salmon, Mark A. Luttmann, James J. Foley, Peter T. Buckley, Dulcie B. Schmidt, Miriam Burman, Edward F. Webb, Christopher J. DeHaas, Charles J. Kotzer, Victoria J. Barrett, Robert J. Slack, Henry M. Sarau, Michael R. Palovich, Dramane I. Lainé, Douglas W. P. Hay and William L. Rumsey
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 260-270; DOI: https://doi.org/10.1124/jpet.112.202051
« Previous (Pages : 1 2 3 4 5 6 ... 13) Next »
Back to top

In this issue

Advertisement